Workflow
行业点评报告:七部门政策激活脑机接口产业
ZHESHANG SECURITIES·2025-08-07 12:10

Investment Rating - The industry investment rating is "Positive" (maintained) [3][6] Core Insights - Recent policies from seven departments in China are aimed at stimulating the brain-computer interface (BCI) industry, encouraging commercialization through local incentives and medical insurance integration [2][4] - The overall goal is to achieve breakthroughs in key technologies by 2027, establish advanced technical, industrial, and standard systems, and significantly enhance innovation capabilities by 2030, fostering globally influential leading enterprises [4] - The report suggests actively monitoring companies within the BCI industry chain, including both upstream hardware/software and downstream medical solution providers [2][4] Summary by Sections Investment Suggestions - Companies to watch in the upstream hardware/software sector include: Entropy Technology, iFlytek, Yanshan Technology, Zhongke Information, Dongfang Zhongke, Yingqu Technology, Nanjing Panda, Lihe Science and Technology, BYD Electronics [2] - In the downstream medical solutions sector, notable companies are: Aipeng Medical, Xiangyu Medical, Chengyitong, Ruimaite, Weisi Medical, Innovation Medical, Sanbo Neuroscience [2] Policy and Development Goals - By 2027, the BCI industry aims to achieve key technological breakthroughs, with products reaching international advanced levels and expanding applications in industrial manufacturing, healthcare, and consumer life [4] - By 2030, the goal is to cultivate 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises, establishing a competitive industrial ecosystem [4] Technical Advancements - Focus on enhancing brain signal sensing capabilities through innovative materials and processes, developing high-performance, low-power brain-machine chips, and integrating AI into decoding processes [4] - Accelerate the development of high-performance products, including both implantable and non-implantable devices, to improve control precision and response speed [4]